Your browser doesn't support javascript.
loading
Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection.
Geng, Qibin; Tai, Wanbo; Baxter, Victoria K; Shi, Juan; Wan, Yushun; Zhang, Xiujuan; Montgomery, Stephanie A; Taft-Benz, Sharon A; Anderson, Elizabeth J; Knight, Audrey C; Dinnon, Kenneth H; Leist, Sarah R; Baric, Ralph S; Shang, Jian; Hong, Sung-Wook; Drelich, Aleksandra; Tseng, Chien-Te K; Jenkins, Marc; Heise, Mark; Du, Lanying; Li, Fang.
Afiliação
  • Geng Q; Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, Minnesota, United States of America.
  • Tai W; Center for Coronavirus Research, University of Minnesota, Saint Paul, Minnesota, United States of America.
  • Baxter VK; Laboratory of Viral Immunology, Lindsley F. Kimball Research Institute, New York Blood Center, New York, New York, United States of America.
  • Shi J; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Wan Y; Division of Comparative Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Zhang X; Laboratory of Viral Immunology, Lindsley F. Kimball Research Institute, New York Blood Center, New York, New York, United States of America.
  • Montgomery SA; Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, Minnesota, United States of America.
  • Taft-Benz SA; Center for Coronavirus Research, University of Minnesota, Saint Paul, Minnesota, United States of America.
  • Anderson EJ; Laboratory of Viral Immunology, Lindsley F. Kimball Research Institute, New York Blood Center, New York, New York, United States of America.
  • Knight AC; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Dinnon KH; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Leist SR; Division of Comparative Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Baric RS; Division of Comparative Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Shang J; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Hong SW; Rapidly Emerging Antiviral Drug Development Initiative, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Drelich A; Division of Comparative Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Tseng CK; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Jenkins M; Rapidly Emerging Antiviral Drug Development Initiative, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Heise M; Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, Minnesota, United States of America.
  • Du L; Center for Coronavirus Research, University of Minnesota, Saint Paul, Minnesota, United States of America.
  • Li F; Center for Immunology, Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, United States of America.
PLoS Pathog ; 17(9): e1009897, 2021 09.
Article em En | MEDLINE | ID: mdl-34492082

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Imunogenicidade da Vacina / Vacinas contra COVID-19 / COVID-19 Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Imunogenicidade da Vacina / Vacinas contra COVID-19 / COVID-19 Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article